Işıl Deniz Aliravci

Evaluation of Latent and Active Tuberculosis Development in Patients Receiving Biologic Agent Therapy: A Retrospective Analysis

ObjectiveTo determine the incidence of active TB in patients re-ceiving biological/tsDMARD therapy and to examinethe effects of LTBI prophylaxis and the level of immu-nosuppression on risk.Material and MethodPatients aged ≥18 years who started biological treat-ment between 2019 a...